Soleus Capital Reports New 5.4% Passive Stake in Palisade Bio, Inc.

On May 27, 2026, Soleus Capital Master Fund, L.P., along with its affiliates and Guy Levy, filed a Schedule 13G disclosing a new 5.4% stake in Palisade Bio, Inc. (PALI). The reporting group beneficially owns 9,353,687 shares of Common Stock as of the event date on May 26, 2026. This position was established through shared voting and dispositive power among the affiliated entities: Soleus Capital, LLC (general partner of the Master Fund), Soleus Capital Group, LLC (managing member of Soleus Capital, LLC), Soleus Capital Management, L.P. (investment manager), and Soleus GP, LLC. Guy Levy serves as the sole managing member of both Soleus Capital Group, LLC and Soleus GP, LLC. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of influencing or changing control of the issuer. The ownership percentage is based on 173,579,670 shares outstanding as reported in the issuer's most recent quarterly report.